Neonatal SEPSIS

score for neonatal sepsis to predict morbidity

score for neonatal sepsis

Faculty Of medicine Cairo University

Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II

Severity Index of Neonatal Septicemia of Cases Admitted at Neonatal Intensive Care Units at CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL Using Score for Neonatal Acute Physiology (SNAP) II

Ahmed Mahmoud Ali Ali Youssef

Doctor

Pediatric Dilated Cardiomyopathy

treatment of anemia.

A Study of Impact of Anemia on Morbidity and Mortality in Children With Dilated Cardiomyopathy

Through clinical manifestations of heart of heart failure and echocardiographic assesment of ventricular function

To measure health related quality of life, to monitor the health of populations over time, or to evaluate the efficacy and effectiveness of clinical therapies of practices using a preference weighted self administered measure.

Mohamed Ahmed Amar

principal investigator

Assiut University

Patients with GM1/GM2-Gangliosidosis or high-grade suspicion for GM1/GM2-Gangliosidosis

For the development of the new biomarkers using the technique of Mass-spectometry, maximal 10 ml blood will be taken via using a dry blood spot filter card. To proof the cor-rect GM1/GM2 diagnosis in those patients where up to the enrollment into the study no genetic testing has been done, sequencing of GM1/GM2 will be done. The analyses will be done at the Centogene AG Am Strande 7 18055 Rostock Germany

Hepato-splenomegaly

Dysostosis Multiplex

Seizures

Mental Retardation

Centogene is one of the leading laboratories focusing on genetic testing for rare hereditary disorders. We now offer more than 2200 routine genetic and biochemical tests.

Children's Hospital, Faculty of Medicine, Ain Shams University

Centogene AG

Amrita Institute of Medical Sciences & Research Centre

Navi Mumbai Institute of Research In Mental And Neurological Handicap (NIRMAN)

Lady Ridgeway Hospital for Children

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

Biomarker for Gangliosidosis: BioGM1 / BioGM2 AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL

New methods, like mass-spectrometry give a good chance to characterize specific metabolic alterations in the blood of affected patients that allow diagnosing in the future the disease earlier, with a higher sensitivity and specificity.

the goal of the study to identify and validate a new biochemical marker from the blood of the affected patients helping to benefit other patients by an early diagnose and thereby with an earlier treatment.

hepatomegaly/epileptični krč

Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II

A Study of Impact of Anemia on Morbidity and Mortality in Children With Dilated Cardiomyopathy

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo